Abi Global Health develops a proprietary deep-technology telehealth platform that integrates AI and machine‑learning with real clinicians to improve speed, effectiveness and quality of care. The company positions its solution for large healthcare stakeholders; current clients include top‑five global pharmaceutical and insurance organisations seeking to expand access while allocating health resources efficiently. Founded in 2016 by Kim‑Fredrik Schneider and Dr. Victor Vicens, Abi’s mission is to make healthcare radically accessible for all. The recent Series A provides growth capital to support continued expansion into additional markets to meet the needs of local, regional and global clients. The announcement highlights the company’s focus on scaling market presence rather than disclosing specific operating metrics or valuation.

Total raised

$5M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2023